Pirfenidone CAS 53179-13-8 daahirnimo ≥99.0% IPF

Sharaxaad Gaaban:

Magaca Kiimikada: Pirfenidone

CAS: 53179-13-8

Daahirsanaanta: ≥99.0%

Muuqashada: Caddaan ilaa Iftiinka Budada Crystalline Jaallaha ah

Tayada Sare, Wax Soo Saarka Ganacsiga

Daawaynta Fibrosis sambabada ee Idiopathic (IPF)

E-Mail: alvin@ruifuchem.com


Faahfaahinta Alaabta

Alaabooyinka La Xiriira

Tags Product

Sharaxaad:

Bixinta Nadiif Sarreysa, Wax Soo Saarka Ganacsiga
Magaca Kiimikada: Pirfenidone
CAS: 53179-13-8

Guryaha Kiimikada:

Magaca Kiimikada Pirfenidone
La mid ah Perfenidone;5-Methyl-1-Phenylpyridine-2(1H) -hal;PFD;S-7701;AMR-69
Lambarka CAS 53179-13-8
Lambarka CAT RF-API108
Heerka Saamiyada In Stock
Qaanuunka molecular C12H11NO
Miisaanka Molecular 185.22
Meesha dhalaalaysa 96.0 ilaa 97.0 ℃
Solubility Ku milmay DMSO
Summada Kiimikada Ruifu

Tilmaamaha:

Shayga Tilmaamaha
Muuqashada Caddaan ilaa iftiin jaale ah budada crystalline
Aqoonsiga IR
daahirnimo ≥99.0%
Khasaare xagga qalajinta ≤0.50%
Sulfated Ash ≤0.20%
Xumaanta Keliya ≤0.50%
Wadarta wasakhda ≤1.0%
Biraha culus ≤20pm
Heerka Imtixaanka Heerka Ganacsiga
Isticmaalka API, Idiopathic Pulmonary Fibrosis (IPF)

Xidhmada & Kaydinta:

Xidhmada: Dhalo, bacda bireed ee aluminium, 25kg / Durbaan kartoonada, ama sida waafaqsan shuruudaha macmiilka.

Xaaladda Kaydinta:Ku kaydi weelasha xiran meel qabow oo qallalan;Ka ilaali iftiinka iyo qoyaanka.

Faa'iidooyinka

1

FAQ:

Codsiga:

Pirfenidone (CAS: 53179-13-8) waxay ku jirtaa koox dawooyin ah oo loo yaqaan wakiilada antifibrotic.Pirfenidone waxay muujisay waxqabadyo xaalado fibrotic oo badan, oo ay ku jiraan kuwa sambabada, kelyaha iyo beerka.Waxay saamaysaa habka difaaca jidhkaaga waxayna yaraynaysaa cadadka fibrosis (nabarrada) ee sambabada.Pirfenidone waa mid ka mid ah labada dawo ee laga ansixiyay Kanada si loogu daweeyo Idiopathic Pulmonary Fibrosis (IPF).Pirfenidone waa horjooge loogu talagalay soosaarka TGF-β iyo TGF-β waxay kicisay wax soo saarka kolajka, waxay yaraynaysaa wax soo saarka TNF-α iyo IL-1β, sidoo kale waxay leedahay sifooyinka anti-fibrotic iyo anti-bararka.Waxaa markii ugu horreysay lagu ansixiyay Japan si loogu daweeyo bukaannada qaba fibrosis sambabada idiopathic ka dib tijaabooyin caafimaad, oo hoos yimaada magaca ganacsiga ee Pirespa by Shionogi, 2008. Waxaa loo oggolaaday isticmaalka Midowga Yurub ee 2011, Kanada ee 2012, iyo in Mareykanka bishii Oktoobar 2014.

Halkan ku qor fariintaada oo noo soo dir